PloS one 2010,
Csibi, Alfredo; Cornille, Karen; Leibovitch, Marie-Pierre; Poupon, Anne; Tintignac, Lionel A; Sanchez, Anthony M J; Leibovitch, Serge A
The mTORC1 pathway is required for both the terminal muscle differentiation and hypertrophy by controlling the mammalian translational machinery via phosphorylation of S6K1 and 4E-BP1. mTOR and S6K1 are connected by interacting with the eIF3 initiation complex. The regulatory subunit eIF3f plays a major role in muscle hypertrophy and is a key target that accounts for MAFbx function during atrophy. Here we present evidence that in MAFbx-induced atrophy the degradation of eIF3f suppresses S6K1 activation by mTOR, whereas an eIF3f mutant insensitive to MAFbx polyubiquitination maintained persistent phosphorylation of S6K1 and rpS6. During terminal muscle differentiation a conserved TOS motif in eIF3f connects mTOR/raptor complex, which phosphorylates S6K1 and regulates downstream effectors of mTOR and Cap-dependent translation initiation. Thus eIF3f plays a major role for proper activity of mTORC1 to regulate skeletal muscle size.
Document information provided by NCBI PubMed
Text Mining Data
mTOR signaling — eIF3f: " The translation regulatory subunit eIF3f
controls the kinase dependent mTOR signaling
required for muscle differentiation and hypertrophy in mouse "
Manually curated Databases
No curated data.